Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


Articles published in Nat Rev Clin Oncol

Retrieve available abstracts of 13 articles:
HTML format
Text format



Single Articles


    May 2019
  1. CUZICK J
    Predicting late recurrence in ER-positive breast cancer.
    Nat Rev Clin Oncol. 2019 May 15. pii: 10.1038/s41571-019-0228.
    PubMed     Text format    


  2. D'ABREO N, Adams S
    Immune-checkpoint inhibition for metastatic triple-negative breast cancer: safety first?
    Nat Rev Clin Oncol. 2019 May 3. pii: 10.1038/s41571-019-0216.
    PubMed     Text format    


    December 2018
  3. RICHMAN J, Dowsett M
    Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer.
    Nat Rev Clin Oncol. 2018 Dec 18. pii: 10.1038/s41571-018-0145.
    PubMed     Text format     Abstract available


    September 2018
  4. PONDE NF, Zardavas D, Piccart M
    Progress in adjuvant systemic therapy for breast cancer.
    Nat Rev Clin Oncol. 2018 Sep 11. pii: 10.1038/s41571-018-0089.
    PubMed     Text format     Abstract available


    June 2018
  5. SIDAWAY P
    Ribociclib effective in HR(+), HER2(-) breast cancer.
    Nat Rev Clin Oncol. 2018 Jun 21. pii: 10.1038/s41571-018-0059.
    PubMed     Text format    


    March 2018
  6. SIDAWAY P
    Breast cancer: Changes in clonal dynamics predict response to palbociclib.
    Nat Rev Clin Oncol. 2018 Mar 20. pii: nrclinonc.2018.
    PubMed     Text format    


  7. SIDAWAY P
    Breast cancer: Fibroblast subtypes alter the microenvironment.
    Nat Rev Clin Oncol. 2018 Mar 6. pii: nrclinonc.2018.
    PubMed     Text format    


    February 2018
  8. ROMERO D
    Breast cancer: Metronomic chemotherapy for elderly and/or frail patients.
    Nat Rev Clin Oncol. 2018 Feb 27. pii: nrclinonc.2018.
    PubMed     Text format    


  9. ROMERO D
    Breast cancer: Recurrent fusions in endocrine-resistant disease.
    Nat Rev Clin Oncol. 2018 Feb 6. pii: nrclinonc.2018.
    PubMed     Text format    


    January 2018
  10. VAZ-LUIS I, Partridge AH
    Exogenous reproductive hormone use in breast cancer survivors and previvors.
    Nat Rev Clin Oncol. 2018 Jan 23. pii: nrclinonc.2017.
    PubMed     Text format     Abstract available


    December 2017
  11. PEREZ-GARCIA J, Cortes J
    Breast cancer in 2017: Spurring science, marking progress, and influencing history.
    Nat Rev Clin Oncol. 2017 Dec 12. pii: nrclinonc.2017.
    PubMed     Text format    


    October 2017
  12. SIDAWAY P
    Breast Cancer: Abemaciclib effective in combination with aromatase inhibition.
    Nat Rev Clin Oncol. 2017 Oct 17. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    


  13. SIDAWAY P
    Breast cancer: LAG3 expression indicates favourable outcomes.
    Nat Rev Clin Oncol. 2017 Oct 10. doi: 10.1038/nrclinonc.2017.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: